ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979